Orion's Important Upcoming Interim Report
Orion Corporation is set to unveil its Interim Report covering the first quarter of 2025 on a Wednesday in late April. The report will be available on the company’s website shortly after its anticipated release at noon EEST.
Details of the Interim Report Release
The much-anticipated Interim Report will present financial insights and operational highlights from Orion’s activities during the first quarter. Following the public announcement, stakeholders can access presentation materials on Orion's dedicated investor webpage to grasp key financial metrics and future outlooks.
Live Webcast and Conference Call for Stakeholders
On the same day, a comprehensive webcast and conference call will take place at 13.30 EEST. This interactive session aims to connect analysts, investors, and media representatives, providing a platform for them to gain deeper insights into the company's performance.
Accessing the Webcast
Individuals interested in joining the live webcast can find a direct link on Orion's investor relations page. Additionally, a recording of the webcast will be made available shortly after the event for those who may not be able to attend live.
Conference Call Registration and Participation
To engage in the conference call, participants must first register using a specified link. Following registration, access details, including phone numbers and a unique conference ID, will be sent out. For those who wish to ask questions during the call, leveraging the designated keypad functionality ensures smooth interaction.
Submitting Questions
Aside from verbal inquiries during the call, participants can submit their questions using the provided webcast question form. This dual avenue for queries highlights Orion's commitment to engaging with its audience and addressing their interests.
Understanding the Silent Period
As the publication date approaches, it's crucial to note that Orion will be adhering to a silent period regarding communications. This practice is standard in maintaining the integrity and fairness of information disclosure prior to the report's release.
Company Background and Commitment to Well-Being
Orion Corporation stands tall as a global player in the pharmaceutical industry with a rich heritage spanning over a century, devotedly working towards enhancing well-being. The company is engaged in the development, manufacture, and marketing of both human and veterinary pharmaceutical products, as well as active ingredients. Orion boasts a vast array of proprietary and generic medications, alongside consumer health products, with primary research efforts focused on oncology and pain management.
Contact Information
The point of contact for investor relations at Orion Corporation is Tuukka Hirvonen, who is readily available for inquiries. Interested parties can reach him directly at +358 10 426 2721 for further information.
Frequently Asked Questions
When will the Interim Report be released?
The Interim Report for January-March 2025 will be published on April 23, 2025.
How can I access the webcast?
The live webcast can be accessed through a link found on Orion's investor relations webpage.
Who can participate in the conference call?
The conference call is open to analysts, investors, and media representatives, requiring prior registration.
What is the significance of the silent period?
The silent period is crucial for maintaining information integrity before the official report's public release.
How does Orion contribute to health?
Orion is dedicated to developing a wide range of pharmaceuticals that treat various health conditions, improving the overall well-being of people globally.
